Asthma, COPD, Lung Cancer News | Treatment & Research Articles
Cuts to Medicare Physician Reimbursement Take Effect After Congress Fails to Pass Legislation
FDA Alert: Pulmonology Drug Approvals, Recalls, and Device …
1 天前 · A frequently updated review of the latest FDA announcements and approvals related to pulmonology. In December and January, the US Food and Drug Administration (FDA) approved new therapies for lung cancer, atopic dermatitis, obstructive sleep apnea (OSA), and cystic fibrosis. The FDA also added a ...
GOLD COPD Report 2025: Key Spirometry and Drug Updates
2024年11月22日 · The 2025 GOLD COPD report, titled “Global Strategy for Prevention, Diagnosis and Management of COPD: 2025 Report,” can now be downloaded from the GOLD website, along with a pocket guide to the report and the “2025 …
Diagnosis & Disease Information - Pulmonology Advisor
2024年4月29日 · Bronchiectasis is a chronic respiratory disease. The American Lung Association estimates that in the United States, bronchiectasis affects 350,000 to 500,000 adults.
News Archive - Pulmonology Advisor
2025年1月17日 · Researchers conducted a systematic literature review for articles published from 1990 to 2024 on integration to examine whether its reputation for enhancing the value of health care by reducing price and cost/spending and improving quality is justified.
Benralizumab Improves Eosinophilic Exacerbations in Asthma, COPD
2025年1月8日 · Benralizumab is effective in treating eosinophilic exacerbations in patients with asthma or chronic obstructive pulmonary disease (COPD), according to study findings published in The Lancet Respiratory Medicine.. Investigators hypothesized that in patients with eosinophilic exacerbations, a benralizumab injection, either alone or in combination with prednisolone, would improve outcomes ...
Interstitial Lung Disease May Be Reliably Identified via LUS in ...
4 天之前 · Lung ultrasound (LUS) may be an effective screening tool with a high negative predictive value for interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) who are asymptomatic, according to study findings published in Chest.. Researchers conducted a multicenter, cross-sectional study from June to December 2023 to assess the use of LUS for ILD diagnosis in patients with ...
GINA 2024 Asthma Update: Revised Recommendations on …
2024年6月28日 · The GINA 2024 asthma update includes new guidance on medications, monitoring, treatment goals, remission, cough variant asthma, children, and more.
News And Features - Pulmonology Advisor
A frequently updated review of the latest FDA announcements and approvals related to pulmonology.
Dupixent Approved as Add-On Maintenance Therapy in COPD
2024年10月1日 · The Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance therapy for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.. The approval was supported by data from the randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS (ClinicalTrials.gov Identifier ...